`
`
`
`
`
`
`
`
`ÿ !"#ÿ$ %ÿ&"ÿ'(ÿ)(*+,-,...+/,01
`23456ÿ89: ÿ3;ÿ:<ÿ=>ÿ ?4@ABCD@ÿ E:4F:ÿGH IÿJC5>ÿ3;ÿ:<
`_:;3ÿ`B<3DMÿWTaT[aUWU[
` KKBLC3Dÿ;@MÿN?DL3ÿ943L@4OÿP>ÿQB<<B:FK
`N?4Oÿ_3F:CDMÿ@C3
`:;?43ÿ@^ÿH?B;Mÿb[]ÿ :;3C;ÿVÿ AA43=B:;3D
`R3<:;3DÿS:K3KMÿTMUUV5=VWWXYZV9PQ
`3cÿ_4?Lÿ dd<B5:;B@Ce _ f
`TMUUV5=VWT[\]V9PQ
`N?4BKDB5;B@CMÿ`3D34:<ÿg?3K;B@C
`S:?K3Mÿ[]MUYTÿ :;3C;ÿJC^4BCL3F3C;
`hijklmknn
`43d43K3C;3DÿAOxjrsÿyzÿyi{|plnpi}
`opqrsÿuvjw
`2@44BKIÿB5E@<KIÿ 4KE;ÿ~ÿ?CC3<<ÿ
`TUWTÿ@4;Eÿ2:463;ÿH;433;
` >>ÿP@ÿT[ZY
`QB<FBCL;@CIÿ_ ÿTXbXX
`e[WUfÿ\]bVXUWW
` F:B<MÿNAA3^B<BCLFC:;>5@F
` ÿ
` ÿÿÿ
`xpqp|ÿwzÿkjl
`2@44BKIÿB5E@<KIÿ 4KE;ÿ~ÿ?CC3<<ÿ
`TUWTÿ@4;Eÿ2:463;ÿH;433;
` >>ÿP@ÿT[ZY
`QB<FBCL;@CIÿ_ ÿTXbXX
`[WUV[]TVXTW\
` F:B<MÿNBL:CF@44BKCB5E@<K>5@F
` ÿÿÿ
`hijklmknn
`43d43K3C;3DÿAOxjrsÿyzÿyi{|plnpi}
`opqrsÿpqlÿw
`eH33ÿ:A@=3ÿ^@4ÿ:DD43KKf
` ÿ
` ÿÿÿ
`xpqp|ÿwzÿkjl
`eH33ÿ:A@=3ÿ^@4ÿ:DD43KKf
` ÿÿÿ
`hijklmknn
`43d43K3C;3DÿAOxjrsÿyzÿyi{|plnpi}
`wqpÿqj}klÿw
`eH33ÿ:A@=3ÿ^@4ÿ:DD43KKf
` ÿ
` ÿÿÿ
`xpqp|ÿwzÿkjl
`eH33ÿ:A@=3ÿ^@4ÿ:DD43KKf
` ÿÿÿ
`>pnpl}jlm
`w{qkl}ÿhjq|jÿwÿlrz
`pnpl}jlm
`w{qkl}ÿhjq|jÿk|kmp}
`
`Hopewell EX1032
`
`1
`
`
`
`DateFiled|#[DocketTet
`01/13/2023 1|COMPLAINTfiled against Aurobindo Pharma Limited, Aurobindo Pharma USA,Inc.
`
`( Filing fee $ 402, receipt number ADEDC—4043418.) — filed by Merck Serono SA,
`Merck KGaA,Ares Trading SA. (Attachments: # 1 Exhibit A—D, # 2 Civil Cover
`Sheet)(apk) (Entered: 01/13/2023)
`
`
`
`01/13/2023 2|Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (apk)
`(Entered: 01/13/2023)
`
`
`
`01/13/2023 3|Supplemental information for patent cases involving an Abbreviated New Drug
`Application (ANDA) — Date Patentee(s) Received Notice: 12/5/2022. Date of
`Expiration of Patent: SEE ANDA FORM.Thirty Month Stay Deadline: 6/5/2025. (apk)
`(Entered: 01/13/2023)
`
`
`
`01/13/2023 4|Report to the Commissioner of Patents and Trademarks for Patent/Trademark
`Number(s) 7,713,947 B2 ;8,377,903 B2 ;10,849,919 B2. (apk) (Entered: 01/13/2023)
`
`
`
`01/13/2023 5|Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Merck KGaA
`for Ares Trading SA, Merck Serono SA filed by Ares Trading SA, Merck KGaA,
`Merck Serono SA.(apk) (Entered: 01/13/2023)
`
`01/13/2023
`
` ÿ
`
`ÿ ÿ ÿ ÿ !
`"
`ÿ# !$ ÿ$ %ÿ !
`"
`ÿ# !$ ÿ&'%ÿ(
`)ÿÿ ÿ*ÿ+%ÿ! ,ÿ $" !ÿ - .+++/(0ÿ.ÿ ÿ"1ÿ !
`
`ÿ'%
` !
`6 !
`Jeremy) (Entered: 01/20/2023)
`'# 0) ,
`ÿ
` %ÿ
` ÿ ÿ7 !! ÿ
`!$ÿ! 4ÿ&('(ÿ ! ÿ8 ÿ9 !
`(ÿ) ,
`)- ! 4ÿ0
`ÿ' ,, $ ÿ
`!$
`ÿ
`!ÿ, ÿ ÿ6
`6ÿ ÿ""! 6 ÿ :ÿ !
`,,
`ÿ) 0ÿ.ÿ ÿ )0ÿ7 6 ÿ
` 4ÿ;(ÿ ÿ
`
`-,!
`ÿ
`ÿ 4ÿ'--ÿ ÿ7( #!1ÿ
`#ÿ' 1ÿ 4ÿ<;;(ÿ) ,
`)- ! 4ÿ0
`+ÿ7 ,
`!ÿ
`ÿ# ÿ
`$$
` !ÿ
`ÿ ÿ ÿ ! $ !
`!ÿ ! $ !
` $" !)0ÿ=%=%>+=ÿ?ÿ@/%==%>ÿ?ÿ@%/+>%>>ÿ?(ÿ) ,
`;ÿ
` ! ÿ' $ ÿ, ! ÿ
`ÿ7 ÿ=(4ÿ 1ÿ
`!,
`! ÿ ! ÿ !
`
`!ÿ! ÿ ! ÿ'%ÿ !
`
`ÿ'ÿ ÿ"1ÿ! ÿ ! ÿ'%ÿ !
` !
`
`ÿ'(ÿ) ,
`<ÿ' $$
`ÿ ÿ ÿ
`ÿ !
`"
`ÿ# !$ ÿ$ ÿ
`ÿ@ÿ !
`"
`ÿ# !$
`&'%ÿ(ÿ
`ÿ(ÿ) #$ 4ÿ5ÿÿ' $$
`ÿ 0) ,
`! , ÿ
`ÿ>0ÿ)0(ÿ)- ! 4ÿ0
`/
` ÿ ÿ
`ÿ8 ÿ3!
`!1ÿ?(ÿA $(ÿ ÿ ÿ# ÿ ÿ
`ÿ# ÿ8
`)3?A0ÿ !ÿ# ÿ ÿ $" !ÿ
`ÿ ÿ
` $ ÿ (ÿ)!9"0ÿ)- ! 4ÿ/0
`=ÿ B ÿ
`ÿ' !6 ÿ
`!ÿ' $$
`%ÿ
`$, ÿ ÿ! ÿ, , !ÿ !6 ÿ
`
` !
`"
`ÿ# !$ ÿ$ ÿ
`ÿ8 !1ÿ>%ÿ%ÿ ÿ"1ÿ! ÿ ! ÿ'%ÿ !
`23 %ÿ !
`
`ÿ'(ÿ) %ÿ8 ! $10ÿ)- ! 4ÿ0
`/ÿ'&'ÿ7 ! ÿ- ÿ"1ÿ !
`
`ÿ'%ÿ !
`'( !
`"
`ÿ# !$ ÿ&'%ÿ(ÿ !6 ÿ
`ÿ%ÿ : !ÿ ÿ(ÿ) %
`8 ! $10ÿ)- ! 4ÿ0
`
`SummonsIssued as to Aurobindo Pharma Limited on 1/13/2023; Aurobindo Pharma
`USA,Inc. on 1/13/2023. (Attachments: # 1 Summons Issued)(apk) (Attachment1
`replaced on 1/19/2023) (ntl). (Entered: 01/13/2023)
`
`01/18/2023
`
`Case Assigned to Judge Gregory B. Williams. Please include the initials of the Judge
`(GBW)after the case number on all documentsfiled. (rjb) (Entered: 01/18/2023)
`
`
`
`01/20/2023 7|AFFIDAVITof Service for Summons, Complaint and related papers served on
`Aurobindo Pharma Limited on January 19, 2023, filed by Ares Trading SA, Merck
`KGaA,Merck Serono SA.(Tigan, Jeremy) (Entered: 01/20/2023)
`
`01/20/2023
`
`SUMMONSReturned Executed by Merck Serono SA, Merck KGaA,Ares Trading
`SA.Aurobindo Pharma USA,Inc. served on 1/20/2023, answer due 2/10/2023. (Tigan,
`
`2
`
`